6Mo·

Fast Track is being discussed for Anktiva in lung cancer. Now it's all happening fast.

attachment

$IBRX (-3,28 %)

7
3 Commentaires

image de profil
Just don't forget to take profits and sell off the hype before everyone else does with small biotech bets 💪🏼
1
image de profil
I intend to hold on for the long term. $IBRX is about to make history - in my opinion.
Afficher la réponse
Participez à la conversation